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Table 1 Presenting demographic and biochemical data of
the Sudanese patients with acute Rift Valley fever
Characteristic Mean (SD)
Age, years 38.7 (14.4)
Serum creatinine, mg/dl 8.9 (4.4)
Blood glucose, mg/dl 128 (14.8)
Total serum bilirubin, mg/dl 4.7 (6.3)
Aspartate aminotransferase, IU 104.5 (84.6)
Alanine aminotransferase, IU 118.1 (261.5)
Total platelets ( 109/l) 155 (62.0)Introduction
The Rift Valley fever (RVF) virus of the family Bunyaviridae is
a cause of zoonotic viral disease.1 Since the first isolation of
the virus in the 1930s, there have been several epidemic
outbreaks in the tropics, mainly in Africa, including Sudan,
the largest country in Africa.2,3 RVF infection in humans can
be acquired through mosquito bites and contact with
infected animals, and vertical transmission has been
reported.3 RVF can present as an uncomplicated acute febrile
illness. However, severe complications, such as hemorrhagic
disease, meningoencephalitis, renal failure, and blindness
have been reported.4,5
In this letter we describe the manifestations, morbidity,
andmortality related to the recent outbreak of RVF in central
Sudan. Eighteen patients (fifteen male and three female)
with symptoms suggestive of RVF (fever, bleeding per ori-
fices, jaundice) were admitted to the intensive care unit of
Wad Medani Hospital during the two-month period of Sep-
tember—November 2007. All these patients were identified
according to a strict case definition,6 and were confirmed to
have RVF by serologic testing (IgM antibody to RVF virus). All
patients were treated in the special RVF unit with strict
barrier and isolation care. Antiviral agents were not avail-
able, but conservative measures such as fresh frozen plasma,
blood, albumin, antibiotics, mechanical ventilation, and
hemodialysis were provided as necessary.
The major clinical characteristics of RVF included a high
frequency of hepatic failure, which occurred in six patients
(33.3%), acute renal failure in four patients (22.2%), and
hemorrhagic manifestations in five patients (27.8%). Six1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.03.029patients (33.3%) presented with blindness and two patients
(11.1%) had meningoencephalitis. There was more than one
manifestation of severe RVF in five patients (27.8%). Eight of
the patients died (44.4%). Hepato-renal failure and severe
anemia due to hemorrhage were the leading causes of death
in these patients (Table 1).
During 2007 many patients presented with symptoms of
RVF at various hospitals in the different Sudanese provinces.
Due to the lack of proper statistics, the precise number of
humans infected in the outbreak of RVF in Sudan is unknown.
It was estimated that the majority of the infections were
subclinical or mild, occurring in persons who did not seek
care. The zoonotic nature of the RVF could explain the male
preponderance in this study, since it is the males who usually
practice farming and care for the livestock, according to
Sudanese traditions. The high case—fatality rate and the
manifestations of RVF in this report are in line with the
observations from neighboring Saudi Arabia.4 However, these
were the manifestations of the acute severe form of RVF;
perhaps subacute or other forms of RVF may occur in the near
future. Generally, it has been estimated that only approxi-
mately 1—2% of RVF infections result in fatal hemorrhagic
fever.7 It has been reported that significant high-prevalence
clusters of RVF encompassed areas that had experienced
previous epidemics of RVF.8
Our findings of a high rate of hepato-renal failure are
consistent with previous observations.4 Increased liver
enzymes are early markers for fatal RVF and the lesions in
the liver are presumed to be the result of a direct effect of
the virus, as the liver is the major site of viral replication.9
Thus this was a case series study and further research is
needed.Published by Elsevier Ltd. All rights reserved.
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